Crista Huff photo

STOCKS

Crista Huff

Editor,

Cabot Undervalued Stocks Advisor

About Crista


Crista's Articles

The number of bankruptcy filings have already reached their previous peak from the 2008 Financial Crisis, and subprime auto loans are experiencing alarming delinquency rates. More than any time in the last 15 years, people are struggling to pay their bills. Maybe you’re overtly bearish, or you just want to be ready when the stock market begins an unmistakable decline. In that case, consider ProShares Short Russell2000 (RWM), suggests Crista Huff, portfolio manager at Freedom Capital Management.
As we embark on our investment journey into 2024, I’m quite disenchanted with US stocks, largely because there are some serious recessionary red flags waving frantically at us. But I do like a small-cap stock in the energy sector, in part because it didn’t just have a huge run-up in November-December 2023 with most other names. It’s called Chord Energy (CHRD), writes Crista Huff, portfolio manager at Freedom Capital Management.
Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company with a mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases, asserts Crista Huff, editor of Cabot Undervalued Stocks Advisor. 
Back on February 19, as it became apparent that a mysterious virus in China had begun reaching across the globe, I named Netflix (NFLX) “The Best Coronavirus Stock,” recalls Crista Huff, editor of Cabot Undervalued Stocks Advisor.

Crista's Videos

Crista Huff, editor of Cabot Undervalued Stocks Advisor, provides a mid-year update on her top stock pick for 2017.